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Cell cycle arrest 
Cell identity 
AMH 
A B S T R A C T   
A naturally occurring bovine model with excess follicular fluid androstenedione (High A4), reduced fertility, and 
polycystic ovary syndrome (PCOS)-like characteristics has been identified. We hypothesized High A4 granulosa 
cells (GCs) would exhibit altered cell proliferation and/or steroidogenesis. Microarrays of Control and High A4 
GCs combined with Ingenuity Pathway Analysis indicated that High A4 GCs had cell cycle inhibition and 
increased expression of microRNAs that inhibit cell cycle genes. Granulosa cell culture confirmed that A4 
treatment decreased GC proliferation, increased anti-Müllerian hormone, and increased mRNA for CTNNBIP1. 
Increased CTNNBIP1 prevents CTNNB1 from interacting with members of the WNT signaling pathway thereby 
inhibiting the cell cycle. Expression of CYP17A1 was upregulated in High A4 GCs presumably due to reduced FOS 
mRNA expression compared to Control granulosa cells. Furthermore, comparisons of High A4 GC with thecal and 
luteal cell transcriptomes indicated an altered cellular identity and function contributing to a PCOS-like 
phenotype.   
1. Introduction 
It is well established that high androgen concentrations, both 
circulating and within the ovary, are associated with ovarian dysfunc-
tion and systemic metabolic issues. Ovarian hyperandrogenism as seen 
with polycystic ovary syndrome (PCOS) causes symptoms such as hir-
sutism, anovulation, and metabolic dysfunction (which also compounds 
fertility problems) (Azziz et al., 2009; Hayek et al., 2016; Padwal, 2020; 
Rosenfield and Ehrmann, 2016). Other causes of hyperandrogenism 
such as congenital adrenal hyperplasia also result in reproductive dis-
ruptions (e.g. precocious puberty), virilization, and metabolic syn-
dromes (Azziz et al., 2004; Hayek et al., 2016; Merke and Bornstein, 
2005; Rosenfield and Ehrmann, 2016). Androgens affect many systems, 
including the hypothalamic-pituitary-gonadal axis. Disrupted regulation 
of gonadotropin releasing hormone and gonadotropins are sufficient to 
substantially impact fertility (Bateman and Patisaul, 2008; Dierich et al., 
1998; Viau, 2002). There are also local effects of androgens on the 
follicular cells within the ovary. The theca cells of the follicle are 
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primarily responsible for converting cholesterol to androgens, while the 
granulosa cells (GCs) convert thecal androgens to estrogens (Mason 
et al., 1994; Young and McNeilly, 2010). However, bovine GCs also 
express enzymes that can convert 17-hydroxy-pregnenolone to the an-
drogens dehydroepiandrosterone (DHEA) and androstenedione (A4) in a 
steroid synthesis pathway that is shared between humans and cattle 
(Conley et al., 1995; Conley and Bird, 1997). Human and bovine GCs 
also express the androgen receptor and can thus respond to local an-
drogens as well as produce them (Hampton et al., 2004; Luo and Wilt-
bank, 2006). 
It can be difficult to isolate local ovarian versus systemic effects on 
fertility in most clinical cases of hyperandrogenism because there is a 
broad spectrum of symptoms (Azziz et al., 2004; Balen et al., 1995). 
Many cases of infertility can occur without excessive circulating an-
drogens (Hayek et al., 2016; Padwal, 2020; Rosenfield and Ehrmann, 
2016) and mild cases of sporadic anovulation can go undetected. Ex-
amination of a cohort of normally menstruating women demonstrated 
that 8–13% of these ‘normal’ women were not consistently ovulating for 
two consecutive reproductive cycles (Hambridge et al., 2013; Lynch 
et al., 2014). While infertility and sporadic anovulation can have a 
plethora of causes, high local concentrations of androgens not accom-
panied by high circulating concentrations of androgens may be a 
contributing factor to these disorders. 
Cattle are a monovulatory species with similar reproductive cycles to 
those of women making them an excellent research model for ovarian 
physiology. In fact, beef cows have many similar ovarian problems 
(Abedaj-Majed and Cupp, 2019). These issues include the spontaneous 
development of ovarian cysts and chronic or sporadic anovulation in 
approximately 10% of females (Smith, 2015; Summers et al., 2014; 
Wiltbank et al., 2002). A population of beef cows within the University 
of Nebraska-Lincoln research herd has been identified with both a theca 
cell molecular phenotype similar to that seen in women with PCOS and 
excessive intrafollicular A4, the predominant androgen in cattle (Sum-
mers et al., 2014). These cows exhibit excess concentrations of A4 in 
their follicular fluid (>30 fold higher than controls). Additionally, these 
cows lack an increase in estradiol (E2) production of similar magnitude 
to the follicular A4 concentrations (only 2–4 fold higher) (Summers 
et al., 2014). 
The identification of this phenotype presents a novel opportunity to 
identify the local ovarian effects of naturally-occurring androgen excess 
in vivo. The primary cause of the increased A4 was identified as excessive 
steroidogenesis in the theca cells of the dominant follicle (Summers 
et al., 2014). The effects of those androgens and how they can lead to 
anovulation have been further investigated by assessing the conse-
quences for the GCs of those same dominant follicles. 
2. Methods 
2.1. 1a. Ethics statement 
All animals were humanely treated and cared for in accordance with 
University of Nebraska-Lincoln IACUC guidelines. The University of 
Nebraska-Lincoln is fully AAALAC accredited and follows NIH guide-
lines. Transcriptomes of granulosa cells were evaluated in this study. 
Only females were used in the current study since we are interested in 
the mechanisms involved with granulosa cell function, which is only 
present in female mammalian species. 
2.2. 1b. Cow classification 
A multi-year, multiple estrous cycle survey of 26 randomly selected 
cows was performed to characterize reproductive phenotypes in the 
University of Nebraska-Lincoln physiology herd located at the Eastern 
Nebraska Research and Extension Center (ENREC) formerly known as 
the Agriculture Research and Development Center (ARDC) (Summers 
et al., 2014). The estrous cycles of these beef cows (75% Red Angus, 25% 
MARC III) were synchronized with two injections of prostaglandinF2α 
(PGF2α) 14 days apart and transrectal ultrasound-guided ovarian follicle 
aspiration was performed 12–36 h after the final PGF2α injection as 
previously described (Summers et al., 2014) and Fig. 1. 
The synchronization protocol in Fig. 1 is the most “natural” syn-
chronization method that does not introduce steroids into the cow to 
alter development of the dominant follicle. Instead, it uses a normally 
expressed factor PGF2α to lyse the corpus luteum causing the most 
advanced follicle to initiate growth and development to an ovulatory 
stage follicle which can be aspirated 12–36 h later and A4 measured in 
ff. 
Follicles aspirated 12–36 time points after PGF2α would not be ex-
pected to have been exposed to a luteinizing hormone (LH) surge. Pre-
vious experiments in our cattle have shown that the LH surge occurs 
56–72 h after PGF2α administration (data not shown) while others have 
shown that the LH surge occurs > 42 h post-PGF2α (Guilbault et al., 
1988; Nkuuhe and Manns 1985). The follicular fluid of the dominant 
follicle was aspirated and separated from GCs by centrifugation. Sub-
sequent radioimmunoassay for E2 and enzyme-linked immunosorbent 
assay (ELISA) for A4 were performed as previously described (Summers 
et al., 2014). Based on these assays, follicles with a high A4 concentra-
tion ([A4] ≥40 ng/mL) and no corresponding increase in [E2] were 
classified as “High A4”, while follicles with an average/Control con-
centration (A4 ≤20 ng/mL) and average [E2] were classified as “Low 
A4” and designated as Controls. 
2.3. Ovariectomy, follicle aspiration and isolation of somatic cells from 
Control and High A4 cows for microarray analysis 
Ovariectomy was performed approximately 36 h after CIDR removal 
(Youngquist et al., 1995). Upon ovariectomy, one follicle, the dominant, 
largest (>10 mm diameter) antral follicle from each cow’s ovaries was 
aspirated/dissected and the GCs (≥94% purity; Romereim et al., 2017) 
and follicular fluid were isolated as previously described (Summers 
et al., 2014). Follicles with a follicular fluid E2:P4 ratio greater than 1 
were classified as estrogen-active (EA; Echternkamp et al., 2004; Sun-
derland et al., 1994). After checking that the largest follicle was EA, the 
granulosa cells were then used for the microarray and subsequent 
quantitative real-time PCR (qPCR), GCs were homogenized in 
Tri-reagent (Sigma-Aldrich) for RNA isolation. 
2.4. Microarray transcriptome analysis 
Four cows with follicular fluid [A4] at the highest end of the High A4 
group (mean A4 = 356 ng/mL, SD = 148; range 203–597 ng/mL) and 
four cows with follicular fluid [A4] at the lowest end of the Control 
Fig. 1. Synchronization Protocol to obtain follicular fluid from dominant 
estrogen-active follicles to classify High A4 and Control (Low A4) cows for 
study. The estrous cycles of these beef cows (75% Red Angus, 25% MARC III) 
were synchronized with two injections of prostaglandinF2α (PGF2α) 14 days 
apart and transrectal ultrasound-guided ovarian follicle aspiration was per-
formed 12–36 h after the final PGF2α injection as previously described (Sum-
mers et al., 2014). 
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group (mean A4 = 1.9 ng/mL, SD = 0.39; range 1.40–2.50 ng/mL) were 
selected for GC transcriptome analysis. After RNA extraction, 200 ng 
RNA for each sample (n = 4 animals for each group) were submitted to 
the University of Nebraska Medical Center Microarray Core facility 
where the Affymetrix Bovine GeneChip® Gene 1.0 ST Array RNA 
expression analysis was performed. Full transcriptome data is available 
from the NCBI GEO repository, Series GSE97017. The microarray results 
were normalized with Robust Multi-Array Averaging. Array analysis was 
then performed using the National Institute of Aging array tool (NIA) 
(http://lgsun.grc.nia.nih.gov/ANOVA/) for Analysis of Variance 
(ANOVA) to determine hierarchical clustering, and correlation between 
replicates. All bioinformatic analyses were performed on transcripts 
above a linear noise threshold of 100. Functional categorization of genes 
was determined by examining the gene descriptions from Entrez Gene 
(NCBI, http://www.ncbi.nlm.nih.gov/gene) and UniProtKB/Swiss-Prot 
(http://www.uniprot.org/). Predicted cell function outcomes were 
assessed with Ingenuity® Pathway Analysis (IPA; Winter 2016 release, 
Qiagen, 2021 January update). Potential miRNA targets were deter-
mined using TargetScan Release 7.1 (June 2016) for mammalian 
microRNAs (http://www.targetscan.org/vert_71/). The Principal 
Component Analysis was performed in NIA array tool (http://lgsun.grc. 
nia.nih.gov/ANOVA/) demonstrating the differences in High A4 and 
Control GCs with small and large luteal cells. Small and large luteal cells 
were previously compared to determine lineage differences with control 
GCs via NIA array and a PCA script (Romereim et al., 2016). 
2.5. Quantitative real-time PCR (qPCR) 
To validate the microarray results, qPCR was performed in triplicate 
on 384-well plates to amplify select targets from cDNA synthesized with 
Superscript III Reverse Transcriptase (Thermo Fisher Scientific) from the 
RNA samples originally used for the microarray using the primers listed 
in Table 1. Power SYBR™ Green Master Mix (Thermo Fisher Scientific) 
was utilized with an Applied Biosystems 7900HT Fast Real-Time PCR 
System. Expression was normalized to the geometric mean of the ribo-
somal RNA products RPL15 and RPL19. The results for each transcript 
are represented as the geometric mean of fold-changes relative to the 
expression of that transcript in the Control GCs. 
2.6. Primary granulosa cell culture 
For cell culture experiments to determine effects of A4 concentration 
on granulosa cells, GCs were isolated from ovaries obtained at a local 
abattoir (JBS, Omaha, NE). Follicles larger than 7 mm in diameter were 
aspirated, the follicular fluid was centrifuged (300×g) 10 min to pellet 
the GCs, and the GC pellet was digested for 15–20 min with a mixture of 
dispase (10 mL, Stem Cell Technologies), collagenase (final concentra-
tion of 1 mg/mL, Stem Cell Technologies), and DNase I (final concen-
tration of 10 μg/mL, Stem Cell Technologies). The cells suspended in 
digestion media were then diluted with culture media (DMEM/F12 
containing 2% FBS and 1% penicillin/streptomycin), counted using a 
Scepter 2.0 Cell Counter (EMD Millipore), and centrifuged to pellet the 
cells again. The cell pellet was resuspended with culture media and 
distributed into 6-well plates at a density of 500,000 cells per well in a 
1:1 mixture of DMEM [low glucose and no phenol red or L-glutamine 
(11,054–001, LifeTech)] and F12 [with L-glutamine (11,765–054, 
LifeTech)] with 1% penicillin/streptomycin (15,140–122, LifeTech) and 
2% FBS (26,140–079, LifeTech). Cells were cultured overnight (14–18 
h) in this medium, and then incubated for 4 h in serum-free medium 
with 1% ITS supplement (51,500–056, LifeTech). The cells were then 
cultured with serum-free medium plus 1% ITS. Treatments were: 1) 
Control (PBS with no FSH or A4), 2) bovine Follicle Stimulating Hor-
mone (0.1 IU/μL) (FSH; AFP-9294C, National Hormone and Peptide 
Program) reconstituted in sterile PBS; 3) FSH plus 4-androsten-3, 17- 
dione (A6030-000, Steraloids) reconstituted in ethanol and then diluted 
in PBS prior to addition to culture media at 1 nM (0.29 ng/mL); 4) FSH 
plus A4 at 100 nM (28.6 ng/mL); and 5) FSH plus A4 at 1 μM (286 ng/ 
mL). Control and FSH-only media had a volume of ethanol added 
equivalent to that included with the highest A4 treatment (10 μL ethanol 
in 500 μL media). Cells were incubated with treated media for 20–22 h, 
and then cells were either lysed with RIPA buffer containing Halt™ 
protease inhibitor cocktail (78,430, Thermo Fisher Scientific) for west-
ern blots or collected for RNA isolation utilizing Tri-Reagent (Sigma) as 
previously described. Two collections of bovine slaughterhouse ovaries 
were used with three replicates per treatment for all A4 concentrations. 
Culture media was collected at end of culture and stored at − 80 C for 
analysis of factors secreted in media. 
2.7. Droplet digital PCR for Catenin Beta Interacting Protein 1 
(CTNNBIP1) 
To determine differences in gene expression of Catenin Beta Inter-
acting Protein 1 (CTNNBIP1), droplet digital PCR (ddPCR) was per-
formed in duplicate on 96-well plates to amplify select targets from 
cDNA synthesized with iScript Advanced (Bio-Rad) from the RNA 
samples collected from slaughterhouse GC cultures using the primers 
listed in Table 2. EvaGreen Master Mix (Bio-Rad) was used and droplets 
were generated utilizing DG6 cartridge (Bio-Rad) and droplet generator 
oil for EvaGreen Supermix (Bio-Rad). After droplets were generated, 
they were placed into a 96-well plate and amplified with the C1000 
Touch Thermal Cycler (Bio-Rad). Once the PCR run was completed, 
droplets were read utilizing the QX200 Droplet reader (Bio-Rad) to 
count number of positive and negative droplets per sample. Concen-
trations were determined per sample volume and expression was 
normalized to 100 copies of RNA products of RPL12. A Student’s t-test 
was used to determine differences between groups with P < 0.05 set for 
significance. 
2.8. AMH ELISA 
Spent culture media from GC Controls, those treated with FSH, and 
FSH plus A4 100 nM (28.6 ng/mL) was analyzed utilizing a commer-
cially available bovine AMH ELISA kit (Ansh Labs, Ca# AL-114). For the 
analysis, culture media was not diluted and followed the manufacture’s 
protocol. The intra-assay CV was 1.96%. A Student’s t-test was utilized 
to determine differences between groups with P < 0.05 set for 
significance. 
Table 1 
qPCR Primers.  
Primer Accession Number Forward Reverse 
CCNA2 NM_001075123.1 AAGCTGGCCTGAATCATTAGTA TCTGAGGTAGGTCTGGTGAA 
CYP17A1 NM_174304.2 GACTCCAGCATTGGCGACCT GGGATGCTGCCACTCCTTCT 
CYP19A1 NM_174305.1 TTCAACAGCAGAGAAGCTGGAA CCACGTTTCTCAGCAAAAATCA 
ECT2 NM_001097573.1 AGGAATGGCGGTAACGGTGA ATGATGGCACTCGCAAAGGAC 
RPL15 NM_001077866.1 TGGAGAGTATTGCGCCTTCTC CACAAGTTCCACCACACTATTGG 
RPL19 NM_001040516.2 CAGACGATACCGTGAATCTAAGAAGA TGAGAATCCGCTTGTTTTTGAA  
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2.9. Western blotting and protein quantification – GC proliferation 
The cell lysates in RIPA buffer plus protease inhibitors were sepa-
rated by size on a 10% polyacrylamide gel using a BioRad MINI-Protean 
system according to the manufacturer’s instructions. The separated 
proteins were transferred to Immobilon-FL membranes (EMD Millipore), 
blocked for 2 h using Odyssey® Blocking Buffer (927–40000, LI-COR), 
and then incubated in Odyssey® Blocking Buffer plus 1% Tween-20 
and the primary antibody (rabbit anti-ACTB antibody, 4967S, Cell 
Signaling Technology; rabbit anti-PCNA antibody, ab29, Abcam; 
Table 3) overnight at 4 ◦C with agitation. After TBST (tris buffered saline 
- Tween 20) washes, blots were incubated in Odyssey® Blocking Buffer 
plus 1% Tween-20 plus the secondary antibody (IRDye 680CW goat anti- 
rabbit IgG, 926–68071, LI-COR, Table 3) for 1–2 h at room temperature 
with agitation. Final TBST and TBS washes were followed by blot image 
acquisition using the LI-COR Odyssey® CLx Imaging System. To quan-
tify the relative amount of protein expressed in each sample, the density 
of each protein band in pixels was determined using ImageJ (http://i 
magej.nih.gov/ij/). ImageJ is a free analysis program that allows for 
density of protein bands to be quantitated by the number of dark pixels 
on a scanned image. ImageJ then was used in conjunction with the file of 
the blot from the LI-COR Odyssy Imaging System to quantitate protein 
bands using the square tool in ImageJ which measures density of pixels 
within the protein band. The density of the protein band for each sample 
was normalized using the density of ACTB and averaged over culture 
experiments. Data were analyzed with prism and an ANOVA was used to 
determine the effect of increased concentration of A4 on PCNA staining 
(a measure of proliferation) in granulosa cells. To determine differences 
between Control and dose of A4 or between A4 doses, Sidaks multiple 
comparisons test with planned comparisons was utilized. The main 
comparisons of interest were – 1) comparison of Control (non-treated 
GCs) vs FSH plus 1 μM A4 (286.4 ng/mL; similar to High A4 cow ff); and 
2) FSH plus 1 μM A4 (286.4 ng/mL-similar to High A4 ff concentrations) 
vs FSH plus A4 1 nM (0.29 ng/mL; similar to Control cow ff A4 con-
centrations). Differences in data were considered to be statistically sig-
nificant at P ≤ 0.05. 
2.10. Western blotting and protein quantification – GC signaling of 
granulosa cell cultures and high A4 and control cows after estrous cycle 
synchronization and aspiration 
Granulosa cells were aspirated in dominant follicles after estrous 
cycle synchronization was conducted as described (Fig. 2 except no 
ovariectomy) to evaluate GCs from EA follicles in the naturally occurring 
high-androgen microenvironment compared to Controls. Transrectal 
ultrasound-guided follicle aspiration, rather than ovariectomy, was 
performed as previously described (Summers et al., 2014, Fig. 2). 
Aspirated samples were immediately centrifuged (300×g) for 10 min. 
After centrifugation, the follicular fluid was decanted from the resulting 
GC pellet. Centrifugation and decanting were repeated and GCs were 
then snap frozen in liquid nitrogen for western blotting. 
Protein was extracted from GCs using RIPA buffer with protease in-
hibitors. Proteins were separated by size on a 10% polyacrylamide gel 
and transferred to Immobilon PVDF membranes (EMD Millipore) for 
protein detection. Membranes were blocked with 5% milk in TBST prior 
to overnight incubation with primary antibody (rabbit anti-AKT1 anti-
body, 9272, Cell Signaling Technology; rabbit anti-phospho-AKT anti-
body, 4060, Cell Signaling Technology; rabbit anti-FOXO1 antibody, 
ab39656, Abcam; rabbit anti-phospho-FOXO1 antibody, 9461, Cell 
Signaling Technology; mouse anti-CTNNB1 antibody, 610,154, BD; 
mouse anti-active-CTNNB1 antibody, 05–665, EMD Millipore; rabbit 
anti-MAPK1/3 antibody, 9102, Cell Signaling Technology; rabbit-anti- 
phospho-MAPK1/2; 4370, Cell Signaling Technology, Table 3). Mem-
branes were rinsed with TBST and incubated with the secondary anti-
body (anti-mouse IgG, 7076, Cell Signaling Technology; anti-rabbit IgG, 
7074, Cell Signaling Technology). Either SuperSignal West Pico 
Table 2 
ddPCR primers utilized for CTNNBIP1 and RPL12 transcripts.  
Primer Accession number Forward Reverse 
CTNNBIP1 XM_024976736.1 TTCTTGTCAGCAAACGCAGGT TTTGTCGCCAGAGCCAAGGT 
RPL12 NM_205797.1 CCACCATGCCGCCTAAGTTC TTTGGAGACAGACCCAGAGGGC  
Table 3 
Primary and secondary antibodies for western blotting.  
Protein Primary Antibody Dilution Substrate 
ACTB mouse monoclonal IgG1 1:10,000 West 
Femto  
Cell Signaling Technology 
(4967S) 
1:2000 West Pico   
1:500 N/A 
MAPK1/3 rabbit polyclonal IgG    
Cell Signaling Technology 
(9102) 
1:1000 West Pico  
p-MAPK1/3 rabbit monoclonal IgG    
Cell Signaling Technology 
(4370) 
1:2000 West Pico  
FOXO1 rabbit polyclonal IgG    
Abcam (ab39656) 1:1000 West Pico  
p-FOXO1 rabbit polyclonal IgG    
Cell Signaling Technology 
(9461) 
1:1000 West Pico  
PCNA mouse monoclonal IgG 
Abcam (ab29) 
1:1000 N/A 
p-AKT1 rabbit monoclonal IgG 1:8000 West 
Femto  
Cell Signaling Technology 
(4060)    
CTNNB1 mouse monoclonal IgG1 1:8000 West 
Femto  
BD Transduction 
Laboratory (610,154)    
Non-p- 
CTNNB1 
mouse monoclonal IgG1K 1:8000 West 
Femto  
Millipore (05–665)    
Specificity Secondary Antibody Dilution Substrate 




Cell Signaling Technology 
(7076) 
1:20,000 (with 
ACTB 1◦ Ab)    
1:2000 West Pico  




Cell Signaling Technology 
(7074) 
1:2000 West Pico  
Anti-rabbit IRDye 680CW IgG 1:5000 N/A  
LI-COR (926–68071)   
ACTB = actin, beta; AKT1 = v-akt murine thymoma viral oncogene homolog 1; 
CTNNB1 = beta catenin; MAPK1/3 = mitogen-activated protein kinase 1 and 3; 
FOXO1 = forkhead box O1; PCNA = proliferating cell nuclear antigen; p =
phosphorylated. 
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Chemiluminesent Substrate (Pierce) (FOXO1, phospho-FOXO1, 
MAPK1/3, phospho-MAPK1/3, Table 3) or SuperSignal West Femto 
Maximum Sensitivity Substrate (Pierce) (AKT1, phosphor-AKT1, 
CTNNB1, active-CTNNB1, Table 3) was added to the membranes and 
protein bands were visualized following exposure on x-ray film. 
Following initial transfer, blots were stripped with Restore Western 
Blot Stripping Buffer (Pierce), re-blocked, and incubated with a mouse 
monoclonal primary antibody against beta actin (mouse anti-ACTB 
antibody, 4967, Cell Signaling Technology, Table 3). Following a 
TBST rinse, membranes were incubated with the secondary antibody 
(anti-mouse IgG, 7076, Cell Signaling Technology, Table 3) and protein 
bands were visualized as previously described. Quantification was 
conducted as described above except band density was measured using 
Adobe Photoshop. A Student’s t-test was used to compare means among 
three different experiments; differences in data was considered to be 
statistically significant at P ≤ 0.05. 
2.11. Collection and fixation of GCs after FSH stimulation 
To obtain histology from GCs in EA follicles from Control and High 
A4 cows, estrous cycles were synchronized and stimulated with FSH 
(Fig. 3). 
Aspirates were centrifuged to remove ff from granulosa cells and 
pellets were resuspended with PBS. After the cell pellet was suspended, 
aliquots of 105 GCs (n = 4 replicates per animal) were placed on ice and 
washed twice with 2% FCS-PBS. Cell pellets were diluted in 100 μl 
chilled 1% BSA-PBS. Cytospin slides were prepared based on manufac-
turer’s instructions (Statspin CytoFuge 2, HemoCue America). Diluted 
cells were aliquoted 100 μl in to each well, the lid was placed over the 
samples and spun at maximum speed (1060×g) for 2 min. Filters were 
gently removed from slides to prevent smearing and slides were exam-
ined to ensure cells annealed properly. Slides were then dried in a 
desiccation chamber overnight. 
2.12. Collection and fixation of antral follicles 
For histology of ovarian follicles, antral follicles (>7 mm diameter) 
were isolated from ovaries obtained at a local abattoir (JBS, Omaha, 
NE). Isolated follicles were placed in chilled 4% paraformaldehyde and 
fixed overnight at 4 ◦C rocking. Follicles were then washed 3 times with 
1x PBS for 5 min at 4 ◦C rocking and then incubated overnight in 1x PBS 
containing 30% sucrose at 4 ◦C rocking. The following day, half of the 
sucrose solution was removed and an equal volume of Optimal Cutting 
Temperature (OCT) compound (Thermo Fisher Scientific) was added 
and the tissue was incubated for 3 h at 4 ◦C rocking. Follicles were then 
arranged at the bottom of a plastic mold filled with OCT and placed in a 
mixture of dry ice and 70% ethanol to allow the samples to freeze. All 
embedded samples were then stored at − 80 ◦C until sectioning. Follicles 
were sectioned at a thickness of 20 μm and mounted on slides for 
immunostaining. 
2.13. Follicle and GC immunohistochemistry for steroidogenic enzymes 
For immunohistochemistry of FSH stimulated GCs from High A4 and 
Control cows and slaughterhouse follicles, sections and cells were fixed 
with 4% paraformaldehyde for 10 min at room temperature. Slides were 
washed three times for 5 min in 1x PBS and then permeabilized with 
0.1% Tween-20 in PBS for 10 min. Slides were then washed for 5 min 
with 1x PBS, then blocked in 30% BSA in PBST (0.05% Tween-20 in 1x 
PBS) for 80 min at room temperature. Slides were incubated with a 
primary antibody (mouse anti-aromatase, 1:100, ab139492, Abcam; 
rabbit anti-CY17A1, 1:50, ABC 392 EMD Millipore) in 3% BSA in PBST 
overnight at 4 ◦C. Slides were washed 5 times for 5 min with 1x PBST 
and then incubated with a secondary antibody (Alexa Fluor 555 goat 
anti-mouse IgG, 1:1000, Thermo Fisher Scientific; Alexa Fluor 488 
donkey anti-rabbit IgG, 1:1000, A21206, Thermo Fisher Scientific) in 
3% BSA in PBST for 2.5 h. Slides were washed 3 times for 5 min in 1x 
PBST, incubated with DAPI (5 ng/mL) in 1x PBS for 5 min and then 
washed 3 times for 5 min with PBS. Slides were mounted with Prolong 
Gold with Antifade (Thermo Fisher Scientific) and sealed. Slides were 
imaged at the University of Nebraska-Lincoln Microscopy Core using the 
Olympus FV3000 laser scanning confocal microscope. Localization of 
CYP17A1 and CYP19A1 was quantified using ImageJ and approximate 
percentages were reported for granulosa cell staining. 
3. Results 
3.1. A high-androgen follicular microenvironment generates differentially 
regulated transcripts in granulosa cells 
During a multi-year, multiple estrous cycle survey to classify bovine 
reproductive phenotypes, the GCs and follicular fluid from dominant 
follicles were isolated (Summers et al., 2014). The purity of GCs was 
determined using immunofluorescence (IF) against smooth muscle 
actin, which is a marker for contaminating theca cells (≥94% in our 
preparation) (Romereim et al., 2016). Based on the previously published 
Fig. 2. Synchronization protocol for obtaining granulosa cells for microarray 
analysis in the High A4 and Control groups. Estrous cycles of cows were syn-
chronized with a modified Co-Synch protocol using gonadotropin releasing 
hormone (GnRH) and a controlled internal drug release device (CIDR; 1.38 g 
progesterone, Zoetis) for 7 days with a PGF2α (25 mg/mL; Lutalyse, Zoetis) 
injection at CIDR removal (Summers et al., 2014). This protocol was utilized so 
all follicle waves that developed would be more synchronized and the dominant 
follicles would be at similar stages of development to allow for less variation 
with gene expression in individual follicles from each cow for the micro-
array analysis. 
Fig. 3. Synchronization protocol to stimulate GCs 
in vivo with FSH and develop multiple follicles to 
obtain GCs. Cow estrous cycles were synchronized 
to collect GCs after FSH for histology via a cytospin 
centrifuge allowing for individual cells to be 
adhered onto slides and the identification of mul-
tiple co-labeled steroid enzyme antibodies. Cows 
were administered two PGF2α injections 14 days 
apart, transrectal ultrasound-guided aspiration of 
the dominant follicle was performed (Summers 
et al., 2014) on day 10 after the last PGF2α to allow for increased follicles to develop (and increased GCs) in response to FSH. Immediately after, a series of FSH 
injections (20 mg/mL injection; 140 mg/mL total; Folltropin-V, Vetoquinol) were given 12 h apart over a 4-day period. On day 12 and 13 of the protocol, PGF2α was 
administered to stimulate regression of any luteal tissue and allow for continued development of antral follicles. Ovariectomy (Youngquist et al., 1995) was per-
formed approximately 24 h after the last PGF2α injection and all antral follicles larger than 7 mm in diameter were aspirated.   
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classifications of the androgen content of the follicular fluid (Summers 
et al., 2014), GC samples were selected and utilized for Affymetrix RNA 
microarray analysis [NCBI GEO GSE97017]. Hierarchical clustering of 
overall transcriptomes demonstrated that GCs can be distinguished by 
the androgen content of their follicle-of-origin (Fig. 4A). While the 
Control or High A4 status of the GCs can be determined by their tran-
scriptomes, the list of differentially regulated transcripts between the 
two categories is surprisingly limited once statistical thresholds (P <
0.005, false discovery rate (FDR) < 0.05, linear noise threshold of 100) 
are applied and unannotated probes are omitted, leaving 60 upregulated 
transcripts and 210 downregulated transcripts (Data in Brief, Snider 
et al., XXXXXXXX). The differentially regulated transcripts with highest 
fold-changes between High A4 and Control GCs are shown in Table 4. A 
full list of the differentially expressed genes can be found in Snider et al. 
XXXXXXX (Data in Brief). Select genes were validated by qPCR (Fig. 4B). 
We also previously validated differential expression of several genes 
between control GCs and other ovarian somatic cells (Romereim et al., 
2016). 
3.2. High-A4 microenvironment results in decreased expression of 
proliferation markers 
The differentially regulated transcripts of the High A4 GCs compared 
to the Control GCs provided insights regarding functional differences 
between the two sets of cells. Using the Ingenuity Pathway Analysis 
(IPA) software, a list of predicted networks with functional significance 
in High A4 compared to control granulosa cells were identified 
(Table 5). The predictions suggested that the High A4 GCs had inhibited 
proliferation, cell cycle progress, and cell survival compared to the 
Control GCs. These IPA predictions were supported by the assessment of 
the functional annotations of all the differentially regulated genes based 
on Entrez and UniProKB databases. The categories with the highest 
representation, based on the 60 upregulated mRNAs, were miRNA, cell 
signaling, and immune function genes (Fig. 5A). The most represented 
categories, based on the 210 downregulated genes, were those involved 
in mitosis and the cell cycle, cellular metabolism, and transcription 
regulation (Fig. 5B). 
To confirm that reduced GC proliferation (the main predicted 
outcome for High A4 GCs) was due to the excess A4 in the follicular fluid 
rather than some other variable, primary GCs obtained from large antral 
follicles of ovaries from a local abattoir were cultured and treated with 
control media, bovine FSH, or bovine FSH and one of three concentra-
tions of A4. The lowest concentration of A4 is on the same order of 
magnitude as the A4 content of the follicular fluid of the Control cows 
(0.29 ng/mL or 1 nM), while the highest concentration of A4 is on the 
same scale as the highest A4 content of follicles from High A4 cows (286 
ng/mL or 1 μM). After 20–22 h of treatment with FSH and/or A4, 
Western blot was performed to quantify the proliferation marker PCNA 
normalized to beta actin (ACTB) (Fig. 6). Treatment with A4 caused 
reduced PCNA in granulosa cells treated with FSH plus 1 μM (290 ng/ 
mL) of A4 compared to FSH plus 1 nM (0.29 ng/mL) A4 similar to that 
found in Control cows. Also the GCs treated with FSH plus 1 μM (286 ng/ 
mL) also had reduced PCNA when compared to GCs with no FSH or A4 
treatment (Fig. 6). 
3.3. Potential regulators of inhibition of granulosa proliferation 
The IPA software was used to predict changes in upstream regulators 
(activation or inhibition) based on the expression differences observed 
in target downstream genes. Based on the differentially regulated tran-
scripts in the High A4 GCs compared to the Control GCs, potential up-
stream regulators of inhibited cell proliferation were identified (Data in 
Brief, Snider et al., XXXX). Additionally, this analysis was used to un-
cover possible regulatory mechanisms that could be driving the tran-
scriptome changes in the High A4 GCs. 
Several predicted miRNAs that may regulate the expression of 
differentially regulated genes in High A4 granulosa cells were identified. 
Ten miRNAs were upregulated in the High A4 GCs, and one miRNA was 
downregulated (Table 6; with fold expression values identified in 
microarray analysis, NIA array tool and IPA). Using TargetScan, 118 
downregulated mRNAs (112 annotated) from the microarray analysis 
were predicted as targets of the upregulated miRNAs (Data in Brief, 
Snider et al., XXXX). Many of these miRNAs can potentially regulate 
more than one mRNA transcripts. The functions of these 112 annotated 
genes are primarily associated with mitosis and the cell cycle, meta-
bolism, and transcription regulation (Fig. 7). 
3.4. High-A4 microenvironment resulted in altered signaling pathway 
activation 
Slaughterhouse GC’s treated with 100 nM A4 compared to controls 
(182.0 ± 4.59 vs 146.0 ± 5.68 pg/mL, respectively) (Fig. 8A) had 
increased AMH production. AMH produced from GCs can inhibit 
Wingless-type mouse mammary tumor virus integration site (WNT) 
signaling pathway by production of CTNNBIP1 (Zhang et al., 2015). The 
WNT signaling pathway is one of the major established cellular prolif-
eration pathways. This pathway was therefore investigated in slaugh-
terhouse GCs treated with increased concentrations of A4 to that in High 
A4 cow follicular fluid. We also evaluated mRNA abundance of 
CTNNBIP1 since this molecule inhibits active beta catenin from 
Fig. 4. Transcriptome comparison between High 
and Control GCs. (A) Hierarchical clustering of the 
transcriptomes identified that the High A4 GCs 
cluster together and the Control GCs cluster 
together. The distance along the x-axis at which 
each branching point occurs represents how similar 
or dissimilar each sample is, with more similar 
samples branching closer to 0. (B) Microarray vali-
dation using qPCR shows that the fold-changes for 
CCNA2, CYP17A1, and ECT2 are of similar magni-
tude, while CYP19A1 is not different using either 
method.   
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interacting with TCF downstream of WNT signaling. Increased 
CTNNBIP1 has been shown to cause cell cycle arrest and apoptosis in 
certain cancers (Park et al., 2017). When GCs were treated with A4, 
there was increased expression of mRNA abundance of CTNNBIP1 
compared to controls (Fig. 8B). 
Using Western blot analysis, the abundance of signal transduction 
pathway proteins that regulate cell proliferation were measured in GCs 
from EA dominant follicles, relative to ACTB. Non-phosphorylated 
CTNNB1 (active beta catenin) (P < 0.02) was greater in High A4 GCs 
(n = 9) compared to Control GCs (n = 17) (Fig. 8C) but no significant 
Table 4 









High A4 Avg 
Expression 
Location Family Function 
12900052 TAAR6 trace amine associated 
receptor 6 





12821429 CYP17A1 cytochrome P450 family 17 
subfamily A member 1 
6.65 103.71 622.87 Cytoplasm Enzyme Steroidogenesis 





12892676 ALDH1A1 aldehyde dehydrogenase 1 
family member A1 
3.19 51.63 188.81 Cytoplasm Enzyme Metabolism 
12822732 CHST15 carbohydrate sulfotransferase 
15 
2.53 274.23 711.00 Plasma 
Membrane 
Enzyme Extracellular matrix 
12819205 AS3MT arsenite methyltransferase 2.50 64.51 150.39 Cytoplasm Enzyme Metabolism 
12834667 PRSS23 protease, serine 23 2.33 662.65 1540.76 Extracellular 
Space 
Peptidase Signaling 
12751697 NDRG4 NDRG family member 4 2.32 314.15 719.73 Plasma 
Membrane 
Other Signaling 
12680976 ATP13A3 ATPase 13A3 2.14 756.15 1569.44 Extracellular 
Space 
transporter Ion transport 
12846005 TTF2 transcription termination 
factor 2 




12796835 KIF15 kinesin family member 15 − 2.04 254.74 133.83 Nucleus Other Mitosis 
12808472 NDC80 NDC80, kinetochore complex 
component 
− 2.08 359.29 175.67 Nucleus Other Mitosis 
12755848 SLC7A5 solute carrier family 7 
member 5 
− 2.09 127.48 64.86 Plasma 
Membrane 
transporter Molecular transport 
12802644 HIST1H4B histone cluster 1 H4 family 
member b 
− 2.12 169.43 84.69 Nucleus Other Chromatin structure 
12740526 NPHS2 NPHS2, podocin − 2.13 126.72 56.27 Plasma 
Membrane 
Other Protein-protein binding 
12780541 IGFBP5 insulin like growth factor 
binding protein 5 
− 2.13 114.88 53.06 Extracellular 
Space 
Other Signaling 
12722357 FBXO32 F-box protein 32 − 2.15 153.06 81.06 Cytoplasm Enzyme Protein degradation 
12718797 DSN1 DSN1 homolog, MIS12 
kinetochore complex 
component 
− 2.17 152.07 73.77 Nucleus Other Mitosis 
12876902 HMMR hyaluronan mediated motility 
receptor 





12862370 PARPBP PARP1 binding protein − 2.18 152.05 71.86 Nucleus Other DNA repair 
12871525 NCAPG non-SMC condensin I complex 
subunit G 
− 2.21 578.57 269.15 Nucleus Other Mitosis 
12898870 PRSS35 protease, serine 35 − 2.23 174.20 76.46 Extracellular 
Space 
Peptidase Signaling 
12825587 CENPU centromere protein U − 2.30 269.11 119.63 Nucleus Other Chromatin structure 
12692009 NUSAP1 nucleolar and spindle 
associated protein 1 
− 2.32 147.90 60.04 Nucleus Other Mitosis 
12805984 GMNN geminin, DNA replication 
inhibitor 
− 2.34 121.91 51.56 Nucleus transcription 
regulator 
DNA replication 
12745867 KNTC1 kinetochore associated 1 − 2.35 329.52 144.28 Nucleus Other Mitosis 
12835737 JUN Jun proto-oncogene, AP-1 
transcription factor subunit 




12815755 KIF22 kinesin family member 22 − 2.39 144.64 56.69 Nucleus Other Mitosis 
12843247 PHGDH phosphoglycerate 
dehydrogenase 
− 2.45 168.49 71.12 Cytoplasm Enzyme Metabolism 
12894921 ESCO2 establishment of sister 
chromatid cohesion N- 
acetyltransferase 2 
− 2.54 466.64 189.13 Nucleus Enzyme Mitosis 




12802519 HIST1H2BM histone cluster 1 H2B family 
member m 
− 2.87 1055.36 397.45 Nucleus Other Chromatin structure 
12687887 FOS Fos proto-oncogene, AP-1 
transcription factor subunit 




12905574 DYNLT3 dynein light chain Tctex-type 
3 
− 3.13 121.89 39.77 Cytoplasm Other Molecular transport 
12774842 AOX1 aldehyde oxidase 1 − 3.30 274.91 81.15 Cytoplasm Enzyme Metabolism 
12761259 SUMO2 small ubiquitin-like modifier 2 − 5.21 955.58 222.36 Nucleus Enzyme Posttranslational 
modification  
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differences were identified in relative protein abundance for phos-
phorylated (inactive) CTNNB1, AKT1 (v-akt murine thymoma viral 
oncogene homolog 1; also known as protein kinase B), phosphorylated 
AKT1, FOXO1 (forkhead box O1), phosphorylated FOXO1, MAPK1/3 
and MAPK1/3 (mitogen-activated protein kinase 1 and 3; also known as 
ERK2 and ERK1), or phosphorylated MAPK1/3. There is the potential for 
increased CTNNBIP1 protein to block WNT signaling, causing cell cycle 
arrest or decreased proliferation. The increase in active beta catenin 
(Fig. 8C) may be a compensatory mechanism to increase available 
substrate to promote granulosa cell survival. 
3.5. Comparison of high A4 GCs and luteal cell transcriptomes 
One major driver of gene expression profile change in GCs is the 
luteinization process. To determine whether GCs in the High A4 follicles 
were undergoing premature luteinization or other changes in their 
cellular function, Principal Component Analysis (PCA) was performed 
on the transcriptomes of the High A4 GCs, the Control GCs, and previ-
ously published microarray data from large luteal cells (LLCs) and small 
luteal cells (SLCs) (Fig. 9A) (Romereim et al., 2016). A graph of Principal 
Component 1 (PC1, including 83.45% of the variance) on the X-axis and 
PC2 on the Y-axis, shows that the distribution of the High A4 GCs along 
the x-axis is shifted towards right falling between Control GCs and the 
LLCs and SLCs; although, some of the High A4 GCs and Control GCs 
overlap (Fig. 9B). 
While the High A4 GCs do not cluster with either of the luteal cell 
populations, a modest shift, suggests some luteal cell-like gene expres-
sion patterns. Therefore, we compared gene expression in High A4 
granulosa cells with our previously published PCA data that identified 
genes that are enriched in LLCs or SLCs as well as genes common to 
either the follicular cells (TCs and GCs) or luteal cells (LLCs and SLCs) 
(Romereim et al., 2016). None of the genes specifically enriched in LLCs 
or SLCs had significantly increased expression in the High A4 GCs 
compared to the Control GCs. Also, there are only three genes that are 
enriched in TCs that are significantly increased in expression in the High 
Table 5 
Ingenuity pathway analysis predicted inhibited functions based on all differen-
tially up and down regulated granulosa cell genes.  
Predicted Inhibited Functions in High A4 GCs p-Value # Molecules 
Alignment of chromosomes 1.42E-14 11 
Cell survival 2.34E-04 43 
Cell viability 2.36E-04 41 
Cytokinesis 1.45E-07 15 
Interphase 3.10E-07 31 
M phase 1.85E-11 22 
Proliferation of cells 2.02E-04 93 
Repair of cells 1.91E-03 6 
Repair of DNA 1.16E-06 18  
Fig. 5. Functions of differentially regulated genes. The functions of each differentially regulated gene as determined by Entrez and UniProt/KB annotations for (A) 
the 60 upregulated transcripts in the High A4 GCs and (B) the 210 downregulated transcripts in the High A4 GCs compared to the Control GCs. 
Fig. 6. Western blot quantification of GC 
proliferation in cell culture. Primary GCs 
pooled from large antral follicles of un- 
classified ovaries were cultured overnight 
and then treated with basal media, FSH (0.1 
IU/μL), or FSH and the indicated A4 con-
centrations for 22 h (n = 3 wells per treat-
ment X 2 slaughterhouse collections). An 
ANOVA demonstrated an effect of androgen 
on PCNA expression (P ≤ 0.05) (A) Western 
blot quantification of the proliferation 
marker PCNA normalized to beta actin 
shows that FSH plus 1uM of A4 (286 ng/mL; 
scale of A4 observed in High A4 cow domi-
nant follicle ff) suppressed PCNA protein 
detected in GCs indicating reduced prolifer-
ation compared to GCs with no treatment. 
Furthermore, FSH plus 1uM A4 (286 ng/mL) 
had reduced PCNA when compared to FSH 
plus 1 nM A4 (scale of A4 observed in Con-
trol cow dominant follicle ff). (B) A repre-
sentative blot is shown. *P < 0.04, **P < 0.01.   
R.M. McFee et al.                                                                                                                                                                                                                               
Molecular and Cellular Endocrinology 531 (2021) 111288
9
A4 GCs (COL4A1, AS3MT, and CYP17A1; Table 7). 
However, there are several transcripts that are enriched in GCs are 
differentially expressed in High A4 GCs (Data in Brief, Snider et al., 
XXXXXXXX). Two of these transcripts (NDRG4 and UNC79) had the 
highest expression in the High A4 GCs compared to all other cell types 
(luteal, thecal). Three transcripts (IGFBP5, SQRDL, and CYBRD1) had 
the lowest expression in the High A4 GCs compared to other cell types- 
Control GC, luteal and thecal). All other genes were significantly lower 
in the High A4 GCs than the Control GCs, which could lead to a shift 
towards the expression levels seen in TCs, LLCs, and SLCs. This includes 
the loss of expression of one of the suggested GC-specific markers: 
RGS17 in High A4 GCs compared to Control GCs (Data in Brief, Snider 
et al., XXXXXXXX). Interestingly, there were 74 differentially expressed 
genes in High A4 GCs that were identified as enriched in luteal cell types 
but not in follicular cells (Control GC and thecal). Alternatively, there 
were 17 genes differentially expressed in High A4 GCs that are enriched 
in follicular compared to luteal cells. Additionally, most of the genes 
indicating a High A4 GC shift towards a luteal expression pattern were 
those involved with mitosis and the cell cycle. 
3.6. Localization of CYP17A1 and CYP19A1 expression in bovine 
ovarian follicles 
Because in vivo and in vitro data showed that excess androgens 
inhibit cell proliferation, and because there was increased CYP17A1 in 
High A4 granulosa cells, localization of enzymes that regulate androgens 
(CYP17A1) and estrogens (CYP19A1) were determined using immuno-
fluorescence. GCs from large antral follicles (>10 mm diameter) from 3 
cows classified as Control and 3 cows classified as High A4 were 
collected after FSH stimulation, affixed to slides via a Cytospin centri-
fuge, and immunofluorescence was performed using antibodies against 
both CYP17A1 and CYP19A1. Although expression of aromatase 
(CYP19A1) in GCs was expected, expression of CYP17A1 was also pre-
sent within GCs, independent of their androgen classification (High A4 
or Control) (Fig. 10). To verify the presence of CYP17A1 protein in 
bovine GCs, immunofluorescence was also conducted in large antral 
follicles (>7 mm diameter, n = 3) isolated from un-classified ovaries 
obtained from cows at a local abattoir. As expected, CYP17A1 expres-
sion was localized to theca cells and CYP19A1 was localized to granulosa 
cells. Unexpectedly, CYP17A1 expression was also localized to GCs 
within antral follicles (Fig. 11). Based on the staining, there was 
Table 6 
Differentially Regulated miRNA in High A4 vs. Control Granulosa Cells.  
Probeset ID Gene Symbol Conserved miRNA Family Description Fold Change Control GC Average High A4 GC Average 
12906595 MIR105A miR-105–5p (and other miRNAs w/seed CAAAUGC) bta-mir-105a 2.18 209.86 437.09 
12791562 MIR211 miR-204–5p (and other miRNAs w/seed UCCCUUU) bta-mir-211 2.20 86.41 171.53 
12774048 MIR2358 Bovine-only, no known conserved family bta-mir-2358 − 1.57 203.90 129.74 
12788834 MIR2364 Bovine-only, no known conserved family bta-mir-2364 1.81 266.92 478.13 
12856465 MIR2427 Bovine-only, no known conserved family bta-mir-2427 1.76 156.55 276.90 
12896347 MIR2481 Bovine-only, no known conserved family bta-mir-2481 1.60 110.71 177.06 
12730564 MIR326 miR-330–5p (and other miRNAs w/seed CUCUGGG) bta-mir-326 1.78 83.98 132.86 
12784970 MIR449B miR-34a-5p (and other miRNAs w/seed GGCAGUG) bta-mir-449b 1.72 104.73 181.11 
12832475 MIR449D Bovine-only, no known conserved family bta-mir-449d 1.58 103.75 152.47 
12829226 MIR483 miR-483–3p (miRNAs w/seed CACUCCU) bta-mir-483 1.64 120.87 194.30 
12829236 MIR584-7 miR-584–5p (and other miRNAs w/seed UAUGGUU) bta-mir-584-7 1.87 82.68 147.75  
Fig. 7. Functions of predicted miRNA targets that are differentially regulated in High A4 GCs. The miRNAs, which were upregulated in High A4 GCs, had 112 unique 
potential mRNA targets that were identified as differentially expressed in the microarray analysis. The functions of these mRNA targets as determined by Entrez and 
UniProt/KB annotations are shown. 
R.M. McFee et al.                                                                                                                                                                                                                               
Molecular and Cellular Endocrinology 531 (2021) 111288
10
approximately 45% CYP17A1 and 55% CYP19A1 expression in gran-
ulosa cells from the large antral follicles. 
4. Discussion 
4.1. Transcriptomes of granulosa cells are distinguishable by the 
androstenedione content of the follicular microenvironment 
Hierarchical clustering clearly distinguishes the transcriptomes of 
Fig. 8. Altered expression of markers involved in 
the WNT signaling pathway in High and Control 
GCs. Primary GCs pooled from large antral follicles 
of un-classified ovaries were cultured overnight and 
then treated with media containing FSH (0.1 IU/μL) 
as the control or with A4 (100 nM) as the treatment. 
(A) ELISA-quantified AMH concentrations in GC 
culture media increased in A4 treatment conditions 
compared to controls. (B) CTNNBIP1 expression 
was measured in GCs by ddPCR, and CTNNBIP1 
expression was increased in A4-treated GCs 
compared to controls. (C) Western blot analysis was 
conducted to detect protein levels for GCs from 
dominant, EA follicles. Beta actin (ACTB) was used 
as an endogenous control. Means were compared 
between GCs classified as High A4 (n = 9) and 
Control (n = 17). Significant increased protein 
expression of non-p-CTNNB1 was observed in High 
A4 GCs compared to controls. *P < 0.05. p =
phosphorylated.   
Fig. 9. Principal Component Analysis and Hierarchical Clustering of High and Control GCs compared to luteal cells. (A) Hierarchical clustering of the individual 
samples within each cell type/group shows that SLCs and LLCs are similar to each other though distinguishable as a cell type, just as High A4 GCs and Control GCs are 
similar but distinct. (B) The Eigenvalues for Principal Component 1 and Principal Component 2 are graphically represented to show the variability between samples. 
The LLCs and SLCs (transcriptomes previously published in Romereim et al., 2016) cluster by cell type. The Control GCs and High A4 GCs overlap, though the High 
A4 GCs are shifted towards the luteal cells based on Principal Component 1. 
Table 7 
Theca cell enriched genes with increased expression in high A4 GCs.  
Probe Set 
ID 
Gene Description Fold Change (High 







(LLC vs GC) 
Fold Change 
(LLC vs TC) 
Fold Change 
(LLC vs SLC) 
12711158 COL4A1 collagen type IV alpha 1 chain 1.588 Towards TC extracellular 
matrix 
2.13 2.736 3.405 
12819205 AS3MT arsenite methyltransferase 2.497 Towards TC metabolism 6.129 21.453 6.709 
12821429 CYP17A1 cytochrome P450 family 17 
subfamily A member 1 
6.649 Towards TC steroidogenesis 11.595 129.714 37.024  
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GCs of preovulatory antral follicles based on their A4 environment; 
however, there are relatively few (270 total) transcripts that were 
significantly different between the High A4 GC and Control GC micro-
array (Fig. 4, Data in Brief, Snider et al., XXXXXXXX). The fact that most 
of the transcriptome is similar between High A4 and Control GCs is not 
surprising, as the samples are from the same cell type and within follicles 
of the same stage. Interestingly, one of the transcripts with the greatest 
increase (6.6 fold) in the High A4 GCs is CYP17A1 (Table 3). This, 
combined with the fact that the expression of CYP19A1 was unchanged, 
corresponds well with the previously identified increases in androgen 
concentrations within antral follicles (Summers et al., 2014). This sug-
gests that production of A4 by the GCs themselves could be contributing 
to the local A4 excess. 
Fig. 10. CYP17A1 and CYP19A1 in bovine High A4 and Control GCs. Representative images of immunostaining for DAPI to identify nuclei (blue), as well as 
CYP17A1 (green) and CYP19A1 (red) expression in GCs aspirated from large antral follicles (>10 mm diameter) of cows classified as Control (n = 3) or High A4 (n =
3) after FSH stimulation (Fig. 3). Merged images identify locations with dual CYP17A1 and CYP19A1 expression (yellow). Scale bar represents 10 μm. 
Fig. 11. Localization of CYP17A1 and 
CYP19A1 expression in bovine ovarian fol-
licles. Representative images of immuno-
staining for DAPI to identify nuclei (blue), as 
well as CYP17A1 (green) and CYP19A1 (red) 
expression in large antral follicles (>7 mm 
diameter) isolated from the ovaries of un- 
classified cows collected at a local abattoir 
(n = 3). There was approximately 45% 
CYP17A1 and 55% CYP19A1 expression in 
granulosa cells. Scale bar represents 20 μm. 
GC, granulosa cells; TC, theca cells.   
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4.2. Proliferation of GCs are inhibited by a high-androstenedione 
microenvironment 
Additional predicted functional consequences of a high-androgen 
microenvironment were identified based on analysis of the microarray 
data with IPA predictive algorithms. The largest category (23%) of 
downregulated gene functions and the majority of the predicted 
inhibited cell behaviors were related to mitosis, the cell cycle, and cell 
proliferation (Fig. 5B, Table 5). Many of the downregulated gene func-
tions that were not directly identified as controlling proliferation can 
also be related to various aspects of the cell cycle such as DNA replica-
tion and repair, chromatin structure, and cytoskeletal dynamics 
(Fig. 5B). The upregulated gene functions were dominated by miRNA 
(26%), signaling (17%), and immune function (14%) (Figs. 5A and 7). 
Typically, GCs continue to proliferate until terminal differentiation 
following the peri-ovulatory LH surge. The effects of A4 on GC prolif-
eration have not been previously investigated, but proliferation of GCs in 
vivo can be inhibited by exogenous dihydrotestosterone (DHT) in rats 
(Kayampilly and Menon, 2012; Pradeep et al., 2002). Thus, to establish 
whether the A4 concentrations were sufficient to cause inhibited pro-
liferation, in vitro granulosa cell culture experiments were performed. 
Treatment with A4 resulted in inhibition of granulosa cell proliferation 
at the greatest A4 dose which was similar to that found in High A4 
follicular fluid (Fig. 6) when compared to the untreated control group. 
The three concentrations of A4 used in this study represent the average 
A4 concentration in Control follicles (1 nM), an intermediate concen-
tration (100 nM), and the highest A4 concentrations in follicles of the 
High A4 population (1 μM). These results demonstrate that increased A4 
is sufficient to cause the reduction in cell proliferation that was pre-
dicted by changes in mRNA abundance. It may be that inhibition of GC 
proliferation limits the number of cells in the GC population as a whole 
and thus, reduces the conversion of theca-derived A4 to E2 (Summers 
et al., 2014). Another potential reason for GC inhibition is due to the 
increased A4 environment. A study by Billig et al. demonstrated gran-
ulosa cells exposed to increased levels of androgens undergo autophagy 
leading to apoptosis due to increased DNA fragmentation (Billig et al., 
1993). Therefore, suppressed GC proliferation may further contribute to 
the local A4 accumulation and increased GC autophagy and apoptosis. 
4.3. Potential regulators inhibiting GC proliferation 
Besides A4 exposure itself, regulatory mechanisms resulting in 
decreased proliferation were investigated. The IPA predictive software 
was able to determine many signaling molecules, drugs, and signaling 
mediators like kinases and phosphatases that could potentially cause 
changes in transcript abundance (Data in Brief, Snider et al., 
XXXXXXXX). The software can also determine likely upstream regula-
tors and/or inhibitors in the transcripts of interest. However, some of the 
predicted molecules are unlikely to be present in the follicle, and others 
do not correspond to known follicular conditions. For example, estrogen 
is a predicted inhibited upstream regulator, but the estrogen concen-
trations of the follicles were not lower in the High A4 cows and the 
expression of the estrogen receptor mRNA is unchanged. There also 
might be a problem in binding affinity of the estrogen receptor or 
increased inhibitor production, however, these were not measured and 
would need to be investigated further. Additionally, neither androgen 
receptor nor any androgens are predicted upstream regulators as acti-
vated by IPA. This may be due to the relative lack of known genetic/ 
molecular interactions for androgens in the IPA database compared to 
estrogen and other molecules. Nevertheless, the predictions do provide 
potential avenues of investigation for future assessments of the in vivo 
phenotype. 
In addition to the intracellular signaling mediators predicted by the 
IPA upstream molecules algorithms, miRNA are possible drivers of the 
inhibited GC proliferation. The ten miRNAs upregulated in the High A4 
GCs could be acting on multiple mRNA targets to inhibit cell cycle 
progression (Data in Brief, Snider et al., XXXXXXXX and Fig. 7). Some of 
these miRNA are known to inhibit tumor cell proliferation including 
miR-211 in ovarian epithelial cancer, miR-326 in brain tumors, miR- 
449B in both ovarian and colon cancer, miR-483 in ovarian and other 
squamous cell cancers, and miR-584 in various types of cancer (Bertero 
et al., 2013; Chen, 2013; Kefas et al., 2009; Ma et al., 2011; Ueno et al., 
2011; Vriens et al., 2012; Wang et al., 2010; Xia et al., 2015; Zheng et al., 
2013). Further investigation is necessary, however, to elucidate the role 
of these miRNA in a bovine ovarian follicle context. 
4.4. High-androstenedione microenvironments may alter cell signaling 
pathways to compensate for altered steroidogenesis and proliferation 
Steroidogenesis and proliferation in GCs are believed to require 
CTNNB1, a transcriptional co-activator within the WNT signaling 
pathway, which is inactivated and degraded upon phosphorylation 
(Castanon et al., 2012; Hernandez Gifford et al., 2009; Liu et al., 2009). 
Prior studies have documented a greater abundance of total CTNNB1 in 
cultured bovine GCs following treatment with FSH, and knockdown of 
CTNNB1 has been shown to inhibit the proliferation of cultured mouse 
GCs (Castanon et al., 2012; Gupta, et al., 2014; Wang et al., 2010). In the 
current study, FSH plus 1 μM A4 treatment inhibited proliferation of 
cultured GCs, and microarray analysis of High A4 GCs indicated inhi-
bition of the cell cycle. Consequently, we predicted that active CTNNB1 
would be less abundant in High A4 GCs compared to Control A4 GCs. 
However, active CTNNB1 was more abundant in High A4 GCs, sug-
gesting that this increase may be a compensatory mechanism. We sug-
gest this, because expression of CTNNBIP1 mRNA abundance (possibly 
via increased AMH concentration) was observed in slaughterhouse 
granulosa cells treated with FSH and A4 at concentrations seen in our 
High A4 cow dominant follicle follicular fluid. The enhanced AMH and 
CTNNBIP1 may lead to reductions in downstream WNT signaling effects 
(Park et al., 2017). 
In GCs, AMH binds to its receptor AMHR2 to regulate cellular pro-
liferation and follicular progression (Poole et al., 2016). Increased AMH 
concentration has been demonstrated to decrease aromatase (CYP19A1) 
activity and inhibit the effects of FSH on follicular progression in rodents 
and women with PCOS (Durlinger et al., 2001; Sacchi et al., 2015). 
Along with decreasing the effect of FSH in GCs, AMH can increase the 
expression of CTNNBIP1 transcripts. The expression of CTNNBIP1 can 
inhibit the action of active CTNNB1 and decrease WNT signaling 
pathway downstream effects (Tago et al., 2000). Reduction in WNT 
signaling leads to increased GC arrest and inhibition of follicular pro-
gression (Durlinger et al., 2001; Park et al., 2017). The increased con-
centration of active CTNNB1 in the High A4 GC may represent a 
compensatory response to reverse inhibition of granulosa cell prolifer-
ation since normally active CTNNB1 translocates to the nucleus and 
binds to other transcriptional regulators such as TCF to increase cellular 
proliferation (Park et al., 2017) or SF1 (NR5A1) to regulate CYP19A1 
(Parakh et al., 2006) and LHCGR expression (Law et al., 2013). CTNNB1 
is predicted through the IPA upstream analysis to be inhibited in the 
High A4 granulosa cells, however we have increased active CTNNB1. 
Normally this increase would indicate that the cell is actively prolifer-
ating through the WNT pathway upon binding of active CTNNB1 and 
TCF. Elevated CTNNBIP1 can block WNT signal transduction by inhib-
iting binding of TCF and active CTNNB1. Thus, we are hypothesizing 
that elevated A4 concentrations are inducing AMH-associated 
CTNNBIP1 expression, to block proliferation through WNT-active 
CTNNB1-TCF mechanisms. The culmination of these events inhibits 
the WNT pathway and may be a cause of the cell cycle arrest and 
apoptosis in granulosa cells from the High A4 cows. 
4.5. CYP17A1, CYP19A1 expression in bovine ovarian follicles 
In GCs, the steroidogenesis pathway prior to ovulation involves the 
conversion of A4 to estrogen with the enzyme aromatase (CYP19A1). 
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These cells lack the capability to produce this androgen and require A4 
produced by theca cells to synthesize estrogens. The enzyme, CYP17A1, 
along with HSD3β is required to convert pregnenolone to A4. However, 
recent studies have found a signaling pathway that causes a silence of 
CYP17A1 in GCs, leading to increased expression of CYP19A1 and the 
production of estrogen. FOS, an integral activator protein has been 
demonstrated to be the key regulator of CYP17A1 expression in both 
theca and granulosa cells, with increased expression in the granulosa 
cells and the opposite in theca cells (Beshay et al., 2007; Patel et al., 
2009). 
Patel et al. demonstrated that suppression of FOS expression in the 
HGL5 human granulosa cell line results in robust increases in CYP17A1 
promoter activity and protein expression (Patel et al., 2009). Other 
studies with KGN cell lines and porcine GCs also demonstrated similar 
results (Huang et al., 2016; Ye et al., 2017). A study by Shanker et al., 
determined increased secretion of androgens in prostatic cancer cells 
suppresses the expression of FOS and JUN transcripts, leading to altered 
androgen-receptor signaling (Shanker et al., 2016). Finally, FOS is under 
expressed in adipose tissue of women diagnosed for PCOS and 3 SNP’s 
within the FOS gene were significantly associated with PCOS suggesting 
that individuals with these SNP’s were more susceptible for developing 
PCOS (Jones et al., 2012). 
Microarray analysis of control and High A4 GCs showed a 3-fold 
down regulation of FOS and 2-fold down regulation of JUN in High A4 
GCs and a 6-fold up-regulation of CYP17A1, which supports previous 
reports of altered expression in GCs (Patel et al., 2009). The increased 
concentration of A4 in follicular fluid of the High A4 cows might be a 
potential pathway for A4-mediated downregulation of FOS and JUN, 
resulting in upregulation of CYP17A1. Together, this provides support 
that High A4 GCs have an altered signaling pathway leading to a loss of 
identity of these cells. 
4.6. High-androstenedione microenvironments may drive partial 
luteinization 
A comparison between the transcriptomes of the High A4 GCs, 
Control GCs, LLCs, and SLCs reveals differentially regulated transcripts 
in High A4 GCs have a luteal-like expression pattern. However, there are 
also other transcripts that are upregulated in High A4 GCs that appear to 
be theca-specific (COL4A1, AS3MT, and CYP17A1; Table 7). We used 
Principal Component Analysis (PCA) to visualize variability and identify 
similarity of cell types. This analysis showed no clear clustering of the 
High A4 GCs with either luteal cell type; but, does show a modest shift of 
the High A4 GCs towards the luteal cells based on PCA 1, which repre-
sents ~84% of the variability between cell types (Fig. 9). The fact that 
some of the Control and High A4 GCs overlap in the PCA graph indicates 
that either the differential gene expression in the High A4 GCs is not 
robust enough to completely separate the two GC populations using 
overall transcriptome data or a larger sample size is necessary to identify 
clear clustering of High A4 GCs separate from Control GCs. 
Further investigation into the High A4 GC identity was performed by 
cross-referencing the set of genes differentially regulated in the High A4 
GCs with published transcriptome data from the follicular (GC and TC) 
and luteal (LLC and SLC) cells of the ovary (Romereim et al., 2016). It is 
apparent that much of the GC-specific gene expression is lost in the High 
A4 GC, but there are also no large increases in the expression of genes 
enriched in luteal cell. Thus, the data does not directly implicate the 
adoption of another cell identity. From the published list of transcripts 
specifically enriched in GCs, the High A4 GCs have 87 GC markers with 
altered expression in the High A4 GCs (Data in Brief, Snider et al., 
XXXX). Five transcripts were either highest or lowest fold-change dif-
ferences in the High A4 GCs compared to all other cell populations, 
indicating a shift away from all other cell types. The other genes were 
expressed highest in the Control GCs, and the High A4 GCs lost magni-
tude of expression bringing their expression levels closer to that of the 
TCs, LLCs, and SLCs. However, none of the identified LLC or SLC markers 
(Romereim et al., 2016) had significantly increased expression in the 
High A4 GCs, and there were only three genes that are TC-enriched 
genes that were significantly increased in expression in the High A4 
GCs (Data in Brief, Snider et al., XXXX). The lack of increased expression 
in genes that are important cell type identifiers suggests that the High A4 
GCs have lost their granulosa cell identity and are neither granulosa cells 
nor luteal cells. This is further supported by 74 changes in expression of 
genes in High A4 GCs that shifted expression towards the shared luteal 
gene profiles, but there were also 17 genes indicating a shift in the 
opposite direction away from luteal patterns. Most of the genes indi-
cating a High A4 GC shift towards a luteal expression pattern were those 
involved with mitosis and the cell cycle (with luteal cells being less 
proliferative than pre-ovulatory GCs). For this reason, the High A4 GCs 
appear to have lost their cellular function and identity. 
Finally, it is possible is that the High A4 GCs are undergoing a change 
that could lead to a persistent or cystic follicle. Bovine and rodent GCs in 
persistent follicles or cysts have been shown to have GCs with reduced 
proliferation (Isobe and Yoshimura, 2007; Salvetti et al., 2009). The 
mechanisms driving inhibition of proliferation in GCs in both a high 
androgen follicular environment and in the case of follicular persistence 
will both benefit from further investigation. 
4.7. Conclusions 
The consequence of a high A4 microenvironment have been inves-
tigated using a unique, naturally occurring bovine model of local 
androgen excess. A thorough analysis of the transcriptomes of the GCs 
from Control follicles and High A4 follicles has determined that a small 
set of differentially represented transcripts has important biological 
relevance to these cells. The High A4 GCs have the potential to 
contribute to the A4 accumulation and are very likely experiencing 
inhibited proliferation. Treatment of GCs with A4 in culture is sufficient 
to decrease expression of the proliferation marker PCNA, increase AMH 
production, and increase CTNNBIP1 expression. The increased expres-
sion of CTNNBIP1 can lead to decreased downstream effects to inhibit 
active CTNNB1 and the WNT signaling pathway, resulting in cell cycle 
arrest. Additionally, potential upstream regulators of proliferation 
including miRNA have been identified. Overall, the consequences of 
excess androgens for GCs are primarily decreased proliferation and loss 
of cell identity. 
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